Home

Boost Entertain Познайте ceramide insulin nature communications 2019 екстра почва динозавър

Dynamic changes of muscle insulin sensitivity after metabolic surgery | Nature  Communications
Dynamic changes of muscle insulin sensitivity after metabolic surgery | Nature Communications

PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced  Lipotoxicity in Muscle Cells | Semantic Scholar
PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar

Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance  through targeting TAK1-dependent signalling.,Nature Communications - X-MOL
Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling.,Nature Communications - X-MOL

Mechanisms of muscle insulin resistance and the cross‐talk with liver and  adipose tissue - Silva Rosa - 2020 - Physiological Reports - Wiley Online  Library
Mechanisms of muscle insulin resistance and the cross‐talk with liver and adipose tissue - Silva Rosa - 2020 - Physiological Reports - Wiley Online Library

PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced  Lipotoxicity in Muscle Cells | Semantic Scholar
PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar

Role of ceramide synthase 2 in G-CSF signaling and G-CSF-R translocation  into detergent-resistant membranes. - Sci. Rep. - X-MOL
Role of ceramide synthase 2 in G-CSF signaling and G-CSF-R translocation into detergent-resistant membranes. - Sci. Rep. - X-MOL

Cell-permeable ceramides increase basal glucose incorporation into  triacylglycerols but decrease the stimulation by insulin in 3T3-L1  adipocytes | International Journal of Obesity
Cell-permeable ceramides increase basal glucose incorporation into triacylglycerols but decrease the stimulation by insulin in 3T3-L1 adipocytes | International Journal of Obesity

Resilient hepatic mitochondrial function and lack of iNOS dependence in  diet-induced insulin resistance - PLOS ONE - X-MOL
Resilient hepatic mitochondrial function and lack of iNOS dependence in diet-induced insulin resistance - PLOS ONE - X-MOL

A Ceramide-Centric View of Insulin Resistance: Cell Metabolism
A Ceramide-Centric View of Insulin Resistance: Cell Metabolism

The role of C16:0 ceramide in the development of obesity and type 2 diabetes:  CerS6 inhibition as a novel therapeutic approach - ScienceDirect
The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach - ScienceDirect

Targeting a ceramide double bond improves insulin resistance and hepatic  steatosis | Science
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis | Science

Targeting a ceramide double bond improves insulin resistance and hepatic  steatosis | Science
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis | Science

SMPDL3b modulates insulin receptor signaling in diabetic kidney disease | Nature  Communications
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease | Nature Communications

The role of C16:0 ceramide in the development of obesity and type 2 diabetes:  CerS6 inhibition as a novel therapeutic approach - ScienceDirect
The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach - ScienceDirect

IJMS | Free Full-Text | Sphingolipid Metabolism: New Insight into Ceramide-Induced  Lipotoxicity in Muscle Cells | HTML
IJMS | Free Full-Text | Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | HTML

Genetic deletion of mast cell serotonin synthesis prevents the development  of obesity and insulin resistance. - Nat. Commun. - X-MOL
Genetic deletion of mast cell serotonin synthesis prevents the development of obesity and insulin resistance. - Nat. Commun. - X-MOL

Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic  vulnerability of prostate cancer | Nature Communications
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer | Nature Communications

Metabolic Messengers: ceramides | Nature Metabolism
Metabolic Messengers: ceramides | Nature Metabolism

Targeting a ceramide double bond improves insulin resistance and hepatic  steatosis | Science
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis | Science

The role of sphingosine‐1‐phosphate in skeletal muscle: Physiology,  mechanisms, and clinical perspectives - Cordeiro - 2019 - Journal of  Cellular Physiology - Wiley Online Library
The role of sphingosine‐1‐phosphate in skeletal muscle: Physiology, mechanisms, and clinical perspectives - Cordeiro - 2019 - Journal of Cellular Physiology - Wiley Online Library

Exosome-Like Vesicles as New Mediators and Therapeutic Targets for Treating  Insulin Resistance and β-Cell Mass Failure in Type 2 Diabetes Mellitus
Exosome-Like Vesicles as New Mediators and Therapeutic Targets for Treating Insulin Resistance and β-Cell Mass Failure in Type 2 Diabetes Mellitus

A selective inhibitor of ceramide synthase 1 reveals a novel role in fat  metabolism | Nature Communications
A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism | Nature Communications

Mechanistic interplay between ceramide and insulin resistance | Scientific  Reports
Mechanistic interplay between ceramide and insulin resistance | Scientific Reports

SMPDL3b modulates insulin receptor signaling in diabetic kidney disease | Nature  Communications
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease | Nature Communications

Palmitic and Oleic Acid: The Yin and Yang of Fatty Acids in Type 2 Diabetes  Mellitus: Trends in Endocrinology & Metabolism
Palmitic and Oleic Acid: The Yin and Yang of Fatty Acids in Type 2 Diabetes Mellitus: Trends in Endocrinology & Metabolism

Ceramides – Lipotoxic Inducers of Metabolic Disorders: Trends in  Endocrinology & Metabolism
Ceramides – Lipotoxic Inducers of Metabolic Disorders: Trends in Endocrinology & Metabolism